Preclinical Assessment of a Zwitterionic Tantalum Oxide Nanoparticle X-ray Contrast Agent

被引:74
作者
Bonitatibus, Peter J., Jr. [1 ]
Torres, Andrew S. [1 ]
Kandapallil, Binil [1 ]
Lee, Brian D. [1 ]
Goddard, Greg D. [1 ]
Colborn, Robert E. [1 ]
Marino, Michael E. [1 ]
机构
[1] GE Global Res Ctr, Niskayuna, NY 12309 USA
关键词
tantalum oxide; nanoparticle; X-ray contrast; zwitterion; GOLD NANOPARTICLES; QUANTUM DOTS; IMIDAZOLIUM SULFONATE; SILICA NANOPARTICLES; SURFACE; FUNCTIONALIZATION; PHOSPHORYLCHOLINE; MONOLAYERS; ENDOTOXIN; CYSTEINE;
D O I
10.1021/nn300928g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tantalum oxide nanoparticles show great potential as the next generation of X-ray contrast media. Recently, we reported advances in tantalum oxide nanoparticles and identified improvements that were required for such particles to progress further. Namely, the viscosity of concentrated particles, the amount of retention in reticuloendothelial (RES) tissues, and the effect of large quantities of particles on the kidneys after administration were all identified as critical factors which needed further study, understanding, and development. Here, we report on a zwitterionic siloxane polymer nanopartide coating that reduced the viscosity of concentrated solutions of particles by a factor of 5, decreased tissue retention of Injected particles by a factor of 10, and, importantly, did not induce pathological responses in the kidneys.
引用
收藏
页码:6650 / 6658
页数:9
相关论文
共 45 条
[1]   Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles [J].
Agasti, Sarit S. ;
Chompoosor, Apiwat ;
You, Chang-Cheng ;
Ghosh, Partha ;
Kim, Chae Kyu ;
Rotello, Vincent M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (16) :5728-+
[2]   WATER-SOLUBLE PALLADIUM AND GOLD NANOPARTICLES FUNCTIONALIZED BY A NEW PHOSPHINE WITH ZWITTERIONIC LIQUID BASED ON IMIDAZOLIUM SULFONATE LINKED ETHYLENE GLYCOL MOIETY [J].
Akiyama, Taichi ;
Ibata, Chiharu ;
Fujihara, Hisashi .
HETEROCYCLES, 2010, 80 (02) :925-931
[3]  
Bon itatebus P.J., 2007, United States Patent Application, Patent No. 20070122620
[4]  
Bonitatibus P.J., 2010, United States Patent Applications, Patent No. 20100278734
[5]  
Bonitatibus P.J., 2010, United States Patent Applications, Patent No. [2010/0278748, 20100278748]
[6]  
Bonitatibus P.J., 2010, United States Patent Applications, Patent No. [20100278749, 2010/0278749]
[7]   Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent [J].
Bonitatibus, Peter J., Jr. ;
Torres, Andrew S. ;
Goddard, Gregory D. ;
FitzGerald, Paul F. ;
Kulkarni, Amit M. .
CHEMICAL COMMUNICATIONS, 2010, 46 (47) :8956-8958
[8]   Zwitterionic Biocompatible Quantum Dots for Wide pH Stability and Weak Nonspecific Binding to Cells [J].
Breus, Vladimir V. ;
Heyes, Colin D. ;
Tron, Kyrylo ;
Nienhaus, G. Ulrich .
ACS NANO, 2009, 3 (09) :2573-2580
[9]   Renal clearance of quantum dots [J].
Choi, Hak Soo ;
Liu, Wenhao ;
Misra, Preeti ;
Tanaka, Eiichi ;
Zimmer, John P. ;
Ipe, Binil Itty ;
Bawendi, Moungi G. ;
Frangioni, John V. .
NATURE BIOTECHNOLOGY, 2007, 25 (10) :1165-1170
[10]  
Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]